Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
Cell Reports
|
August 19, 2023
Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors
Michael B Mumphrey, Noshad Hosseini, Abhijit Parolia, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Effects of calreticulin deficiency and myeloproliferative neoplasm (MPN)-linked mutation on cellular calcium signaling
Ishmael Nii Ayibontey Tagoe, Amanpreet Kaur, Osbourne Quaye, et al.
The Journal of Cell Biology
|
April 28, 2021
Mechanism of mutant calreticulin-mediated activation of the thrombopoietin receptor in cancers
Arunkumar Venkatesan, Jie Geng, Malathi Kandarpa, et al.
The Journal of Biological Chemistry
|
December 5, 2009
Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway
Natasha Del Cid, Elise Jeffery, Syed Monem Rizvi, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
Mass spectrometric profiling of HLA-B44 peptidomes provides evidence for tapasin-mediated tryptophan editing
Amanpreet Kaur, Avrokin Surnilla, Anita J Zaitouna, et al.
Elife
|
July 11, 2018
Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity
Brogan Yarzabek, Anita J Zaitouna, Eli Olson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 22, 2023
Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing
Amanpreet Kaur, Avrokin Surnilla, Anita J Zaitouna, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 6, 2016
Update on Gender Equity in Immunology, 2001 to 2016
Virginia Smith Shapiro, Susan Kovats, Michelle A Parent, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 3, 2014
Distinct assembly profiles of HLA-B molecules
Syed Monem Rizvi, Nasir Salam, Jie Geng, et al.
Scientific Reports
|
January 3, 2024
Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
Cindy Y Jiang, Lili Zhao, Michael D Green, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
Cell Reports
|
August 19, 2023
Distinct mutational processes shape selection of MHC class I and class II mutations across primary and metastatic tumors
Michael B Mumphrey, Noshad Hosseini, Abhijit Parolia, et al.
Biorxiv : the Preprint Server for Biology
|
July 16, 2025
Effects of calreticulin deficiency and myeloproliferative neoplasm (MPN)-linked mutation on cellular calcium signaling
Ishmael Nii Ayibontey Tagoe, Amanpreet Kaur, Osbourne Quaye, et al.
The Journal of Cell Biology
|
April 28, 2021
Mechanism of mutant calreticulin-mediated activation of the thrombopoietin receptor in cancers
Arunkumar Venkatesan, Jie Geng, Malathi Kandarpa, et al.
The Journal of Biological Chemistry
|
December 5, 2009
Modes of calreticulin recruitment to the major histocompatibility complex class I assembly pathway
Natasha Del Cid, Elise Jeffery, Syed Monem Rizvi, et al.
Biorxiv : the Preprint Server for Biology
|
March 13, 2023
Mass spectrometric profiling of HLA-B44 peptidomes provides evidence for tapasin-mediated tryptophan editing
Amanpreet Kaur, Avrokin Surnilla, Anita J Zaitouna, et al.
Elife
|
July 11, 2018
Variations in HLA-B cell surface expression, half-life and extracellular antigen receptivity
Brogan Yarzabek, Anita J Zaitouna, Eli Olson, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 22, 2023
Mass Spectrometric Profiling of HLA-B44 Peptidomes Provides Evidence for Tapasin-Mediated Tryptophan Editing
Amanpreet Kaur, Avrokin Surnilla, Anita J Zaitouna, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
November 6, 2016
Update on Gender Equity in Immunology, 2001 to 2016
Virginia Smith Shapiro, Susan Kovats, Michelle A Parent, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 3, 2014
Distinct assembly profiles of HLA-B molecules
Syed Monem Rizvi, Nasir Salam, Jie Geng, et al.
Scientific Reports
|
January 3, 2024
Class II HLA-DRB4 is a predictive biomarker for survival following immunotherapy in metastatic non-small cell lung cancer
Cindy Y Jiang, Lili Zhao, Michael D Green, et al.
Page
of 7